FORM 8-K


                       SECURITIES AND EXCHANGE COMMISSION


                             Washington, D.C. 20549



                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


       Date of Report (Date of earliest event reported): October 24, 2002



                             MEDTOX SCIENTIFIC, INC.
             (Exact name of registrant as specified in its charter)


                                    Delaware
                 (State or other jurisdiction of incorporation)


1-11394                                                  95-3863205
(Commission File Number)                       (IRS Employer Identification No.)


402 West County Road D
St. Paul, Minnesota                                                      55112
(Address of principal executive offices)                              (Zip Code)


                                 (651) 636-7466
              (Registrant's telephone number, including area code)







Item 9.           Regulation FD Disclosure

     On October 24, 2002,  the  company's  CEO  presented to investors at Profit
Journal's Upper Midwest Small-Cap  Conference in Minneapolis,  MN. A copy of the
presentation is attached as Exhibit 99.1.







                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                                        MEDTOX Scientific, Inc.




Date:  October 24, 2002                          By:    /s/ Richard J. Braun
                                               Name:    Richard J. Braun
                                              Title:    Chief Executive Officer